Effects of HER2 immuno-histochemistry expression levels on survival in patients treated by trastuzumab at the adjuvant setting in the SIGNAL/PHARE prospective cohort
Curtit, E., Vincent-Salomon, A., Paget-Bailly, S., Romieu, G., Fumoleau, P., Bonnefoi, H., Jouannaud, C., Petit, T., Darut-Jouve, A., Trillet-Lenoir, V., Tarpin, C., Pierga, J-Y., Rios, M., Jacquin, JVolume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw364.40
Date:
October, 2016
File:
PDF, 66 KB
2016